Norman Tabler, Jr.

Faegre Drinker Biddle & Reath LLP

+ Follow Contact

Latest Posts › Manufacturers

Share:

Court Finds FDA Explanation of Knee Implant Reversal Lame

The FDA had approved the mesh—called the Collagen Scaffold—in December 2008. But after the change in administrations the following month, the agency decided that the approval process had been flawed and had been the focus of...more

9/30/2014 / Food and Drug Administration (FDA) , Healthcare , Manufacturers , Medical Devices , Revocation

What’s an MDDS? And Why Should I Care?

Last month the Food & Drug Administration (FDA) announced still further relaxation of its oversight over anything qualifying as a “medical device data system,” or MDDS. The announcement should come as welcome news to a great...more

8/1/2014 / Draft Guidance , Food and Drug Administration (FDA) , Hospitals , Manufacturers , Medical Device Data System , Medical Devices , Physicians , Software

CMS Wants To Shine Light On CME Payments To Physicians

It’s a question CMS has been wrestling with since the enactment of the Sunshine Act (sometimes called the Open Payments Program) as part of the Affordable Care Act. The Sunshine Act generally requires a manufacturer to...more

7/10/2014 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Healthcare , Manufacturers , Medical Devices , Pharmaceutical Industry , Physician Medicare Reimbursements , Physician Payments , Sunshine Act

Study Links 340b Increase To Hospital Acquisition Of Physician Practices

The 340B program requires pharmaceutical manufacturers with Medicaid-covered products to give discounts on covered drugs purchased by eligible entities, which include disproportionate share hospitals, critical access...more

6/3/2014 / Healthcare , Healthcare Reform , Hospitals , Manufacturers , Medicaid , Pharmaceutical Industry , Physicians , Prescription Drugs , Section 340B

4 Results

View per page

Page: of 1